About Trametinib Dimethyl Sulfoxide
            
            Class: | Antineoplastic agent, MEK inhibitor  
Use: | Treatment of unresectable or metastatic melanoma with BRAF V600E or V600K mutations, in combination with dabrafenib; also used for the treatment of non-small cell lung cancer (NSCLC) with BRAF V600E mutations.  
Adult dose: | 2 mg orally once daily, taken continuously until disease progression or unacceptable toxicity; may be adjusted based on tolerability.  
Pediatric dose: | Safety and efficacy not established in pediatric patients; use is 
         
        
            
                
                
                    
                        Drug Class
                    
                    Antineoplastic agent, MEK inhibitor
                 
                
                
                    
                        Uses & Indications
                    
                    Treatment of unresectable or metastatic melanoma with BRAF V600E or V600K mutations, in combination with dabrafenib; also used for the treatment of non-small cell lung cancer (NSCLC) with BRAF V600E mutations.
                 
                
                
                    
                        Storage Requirements
                    
                    Store at 20°C to 25°C (68°F to 77°F); protect from moisture and light.
                 
                
                
                    
                        Manufacturer & Packaging
                    
                    
                        Manufacturer: NOVARTIS EUROPHARM LIMITED, IRELAND
                    
                    
                    Package Size
                    30's
                    
                    
                    Price & Supplier
                    
                        Price in UAE: AED 5521.20
                    
                    
                 
             
            
                
                
                    
                        Dosage Information
                    
                    
                        Adult Dose
                    
                    
                        2 mg orally once daily, taken continuously until disease progression or unacceptable toxicity; may be adjusted based on tolerability.
                    
                    
                        Pediatric Dose
                    
                    
                        Safety and efficacy not established in pediatric patients; use is not recommended.
                    
                 
                
                
                    
                        Side Effects
                    
                    Common side effects include rash, diarrhea, edema, fatigue, nausea, and elevated liver enzymes.
                 
             
         
        
        
            
                Contraindications & Precautions
            
            Hypersensitivity to trametinib or any component of the formulation; pregnancy (Category D).
         
        
        
            
                Important Warnings
            
            Risk of serious skin reactions, including rash and dermatitis; risk of cardiomyopathy; monitor for signs of bleeding; may cause fetal harm; avoid use during pregnancy and breastfeeding.
         
        
        
        
        
        
        
        
        
        
        
            
                Medical Disclaimer
            
            
                This information is for educational purposes only and should not replace professional medical advice. 
                Always consult with a licensed healthcare provider or pharmacist in the UAE before taking any medication. 
                The information presented here is specific to medicines available in UAE pharmacies and is regularly updated 
                to ensure accuracy for patients and healthcare professionals in the United Arab Emirates.